Determination of casopitant and its three major metabolites in dog and rat plasma by positive ion liquid chromatography/tandem mass spectrometry
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences - Tập 878 - Trang 2974-2982 - 2010
Tài liệu tham khảo
Minthorn, 2008, Drug Metab. Dispos., 36, 1846, 10.1124/dmd.108.021758
Leslie, 1985, Neurochem. Int., 7, 191, 10.1016/0197-0186(85)90106-8
Kramer, 1998, Science, 281, 1640, 10.1126/science.281.5383.1640
Holmes, 2003, Trends Pharmacol. Sci., 24, 580, 10.1016/j.tips.2003.09.011
Kramer, 2004, Neuropsychopharmacology, 29, 385, 10.1038/sj.npp.1300260
Furmark, 2005, Biol. Psychiatry, 58, 132, 10.1016/j.biopsych.2005.03.029
Warr, 2005, J. Clin. Oncol., 23, 2822, 10.1200/JCO.2005.09.050
Quartara, 2009, Expert Opin. Investig. Drugs, 18, 1843, 10.1517/13543780903379530
Herrstedt, 2009, J. Clin. Oncol., 27, 5363, 10.1200/JCO.2009.21.8511
Khojasteh, 2009, Expert Opin. Pharmacother., 10, 1367, 10.1517/14656560902953746
S. Pagliarusco, S. Martinucci, E. Bordini, L. Miraglia, D. Cufari, L. Ferrari, M. Pellegatti, Drug Metab. Dispos. (unpublished results).
L. Miraglia, S. Pagliarusco, E. Bordini, S. Martinucci, M. Pellegatti, Drug Metab. Dispos. (in press).
Pellegatti, 2009, Drug Metab. Dispos., 37, 1635, 10.1124/dmd.109.026781
Viswanathan, 2007, AAPS J., 9, E30, 10.1208/aapsj0901004
Guidance for Industry: Bioanalytical Method Validation, US Food and Drug Administration (FDA), Rockville, MD, May 2001.